BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Morcos SK, Haylor J. Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data. World J Radiol 2010; 2(11): 427-433 [PMID: 21179310 DOI: 10.4329/wjr.v2.i11.427]
URL: https://www.wjgnet.com/1949-8470/full/v2/i11/427.htm
Number Citing Articles
1
Emmanuil Smorodinsky, David S. Ansdell, Zeke W. Foster, Sameer M. Mazhar, Irene Cruite, Tanya Wolfson, Sebastian B. Sugay, Gabriella Iussich, Masoud Shiehmorteza, Yuko Kono, Alexander Kuo, Claude B. Sirlin. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agentsJournal of Magnetic Resonance Imaging 2015; 41(5): 1259 doi: 10.1002/jmri.24650
2
Claudia Guanci, Roberta Pinalli, Silvio Aime, Eliana Gianolio, Luciano Lattuada, Giovanni B. Giovenzana. Synthesis of phosphonic analogues of AAZTA†AAZTA=6-Amino-6-methylperhydro-1,4-diazepine-N,N′,N″,N″-tetraacetic acid.† and relaxometric evaluation of the corresponding Gd(III) complexes as potential MRI contrast agentsTetrahedron Letters 2015; 56(15): 1994 doi: 10.1016/j.tetlet.2015.02.118
3
Michael Lauterbach. Internistische Intensivmedizin und Notfallmedizin2011; : 189 doi: 10.1007/978-3-642-16970-0_20
4
Zsolt Baranyai, Zoltán Pálinkás, Fulvio Uggeri, Alessandro Maiocchi, Silvio Aime, Ernő Brücher. Dissociation Kinetics of Open‐Chain and Macrocyclic Gadolinium(III)‐Aminopolycarboxylate Complexes Related to Magnetic Resonance Imaging: Catalytic Effect of Endogenous LigandsChemistry – A European Journal 2012; 18(51): 16426 doi: 10.1002/chem.201202930
5
Roberto Artali, Zsolt Baranyai, Mauro Botta, Giovanni B. Giovenzana, Angelo Maspero, Roberto Negri, Giovanni Palmisano, Massimo Sisti, Stefano Tollari. Solution thermodynamics, computational and relaxometric studies of ditopic DO3A-based Mn(ii) complexesNew Journal of Chemistry 2015; 39(1): 539 doi: 10.1039/C4NJ01571A
6
Gabriele Rolla, Valeria De Biasio, Giovanni B. Giovenzana, Mauro Botta, Lorenzo Tei. Supramolecular assemblies based on amphiphilic Mn2+-complexes as high relaxivity MRI probesDalton Transactions 2018; 47(31): 10660 doi: 10.1039/C8DT01250D
7
S. Baroni, Sonia Colombo Serra, Alberto Fringuello Mingo , G. Lux, G. B. Giovenzana, L. Lattuada. Synthesis and Relaxometric Characterization of a New Mn(II)‐EDTA‐Deoxycholic Acid Conjugate Complex as a Potential MRI Blood Pool AgentChemistrySelect 2016; 1(8): 1607 doi: 10.1002/slct.201600349
8
Quyen N. Do, Robert E. Lenkinski, Gyula Tircso, Zoltan Kovacs. How the Chemical Properties of GBCAs Influence Their Safety Profiles In VivoMolecules 2021; 27(1): 58 doi: 10.3390/molecules27010058
9
E. S. Kamyshova, N. L. Shimanovskii. MRI with Contrast Enhancement in a Patient with Chronic Kidney Disease: to Contrast Have Not Be Denied. Where Should We Put the Comma?Journal of radiology and nuclear medicine 2019; 100(1): 58 doi: 10.20862/0042-4676-2019-100-1-58-66
10
John N. Morelli, Clint M. Gerdes, Peter Schmitt, Tao Ai, Megan R. Saettele, Val M. Runge, Ulrike I. Attenberger. Technical considerations in MR angiography: An image‐based guideJournal of Magnetic Resonance Imaging 2013; 37(6): 1326 doi: 10.1002/jmri.24174
11
Vinant Bhargava, Kulwant Singh, Priti Meena, Rupan Sanyal. Nephrogenic systemic fibrosis: A frivolous entityWorld Journal of Nephrology 2021; 10(3): 29-36 doi: 10.5527/wjn.v10.i3.29
12
Sema Yildiz, Hasan Cece, Ihsan Kaya, Hakim Celik, Abdullah Taskin, Nurten Aksoy, Abdurrahim Kocyigit, Mehmet A. Eren. Impact of contrast enhanced MRI on lymphocyte DNA damage and serum visfatin levelClinical Biochemistry 2011; 44(12): 975 doi: 10.1016/j.clinbiochem.2011.05.005
13
Hana Malikova, Michal Holesta. Gadolinium Contrast Agents - Are they Really Safe?The Journal of Vascular Access 2017; 18(2_suppl): S1 doi: 10.5301/jva.5000713
14
Riccarda Delfino, Matteo Biasotto, Riccardo Candido, Matteo Altissimo, Marco Stebel, Murielle Salomè, Johannes T. van Elteren, Katarina Vogel Mikuš, Cristina Zennaro, Martin Šala, Riccardo Addobbati, Giuliana Tromba, Lorella Pascolo. Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agentsToxicology Letters 2019; 301: 157 doi: 10.1016/j.toxlet.2018.11.014
15
Jennifer Nashel, Virginia Steen. Scleroderma MimicsCurrent Rheumatology Reports 2012; 14(1): 39 doi: 10.1007/s11926-011-0220-8
16
Peter J. Wermuth, Sergio A. Jimenez. Scleroderma2012; : 137 doi: 10.1007/978-1-4419-5774-0_13
17
Sonsoles Piera-Velazquez, Peter J. Wermuth, Juan J. Gomez-Reino, John Varga, Sergio A. Jimenez. Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesisSeminars in Arthritis and Rheumatism 2020; 50(6): 1226 doi: 10.1016/j.semarthrit.2020.09.003
18
Lilliam S. Chiqués Colón, Rosbel González Rivera. Atlas of Dermatology in Internal Medicine2012; : 31 doi: 10.1007/978-1-4614-0688-4_3
19
Nadia D. Morgan, Laura K. Hummers. Scleroderma MimickersCurrent Treatment Options in Rheumatology 2016; 2(1): 69 doi: 10.1007/s40674-016-0038-7
20
Beatrice Nardone, Elise Saddleton, Anne E. Laumann, Beatrice J. Edwards, Dennis W. Raisch, June M. McKoy, Steven M. Belknap, Christian Bull, Anand Haryani, Shawn E. Cowper, Ali K. Abu-Alfa, Frank H. Miller, Victoria Godinez-Puig, Vikas R. Dharnidharka, Dennis P. West. Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR reportPediatric Radiology 2014; 44(2): 173 doi: 10.1007/s00247-013-2795-x
21
J.-M. Idée, N. Fretellier, M.M. Thurnher, B. Bonnemain, C. Corot. Physico-chimie et profil toxicologique d’agents de contraste pour l’imagerie par résonance magnétique, les chélates de gadoliniumAnnales Pharmaceutiques Françaises 2015; 73(4): 266 doi: 10.1016/j.pharma.2015.01.001